MedTrace Logo

Pediatric NMOSD Observational Study

NCT03766347 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-04-10

No results posted yet for this study

Summary

This study is being done to develop a database of pediatric patients in order to study the cause, early detection and best treatment for neuromyelitis optica spectrum disorder (NMOSD) in pediatric patients.

Conditions

  • Neuromyelitis Optica
  • NMO Spectrum Disorder

Sponsors & Collaborators

  • Alexion Pharmaceuticals, Inc.

    collaborator INDUSTRY

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Sean J Pittock, M.D. · Mayo Clinic

Eligibility

Min Age
2 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2024-04-03
Completion
2024-04-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03766347 on ClinicalTrials.gov